Mutation of Epigenetic Regulators at Diagnosis Is an Independent Predictor of Tyrosine Kinase Inhibitor Treatment Failure in Chronic Myeloid Leukemia: A Report From the RESIDIAG Study.
Guerineau H,Cayuela J,Dulucq S,Tran Quang V,Tarfi S,Gricourt G,Barathon Q,Joy C,Wagner-Ballon O,Morisset S,Nicolini F,Brunet E,Maury S,Roy L,Etienne G,Réa D,Sloma I
Source :
2024 Dec 10
Pmid / DOI:
39654506
Abstract
KEYWORDSASXL1, CML resistance, aCAP‐seq, chronic myeloid leukemia, epigenetic, tyrosine kinase inhibitor